Cekic, M., and D. G. Stein. 2010. Traumatic brain injury and aging: Is a combination of progesterone and vitamin D hormone a simple solution to a complex problem? Neurotherapeutics 7(1):81–90.

Chang, E. F., C. P. Claus, H. J. Vreman, R. J. Wong, and L. J. Noble-Haeusslein. 2005. Heme regulation in traumatic brain injury: Relevance to the adult and developing brain. Journal of Cerebral Blood Flow and Metabolism 25(11):1401–1417.

Cole, J. T., C. M. Mitala, S. Kundu, A. Verma, J. A. Elkind, I. Nissim, and A. S. Cohen. 2010. Dietary branched chain amino acids ameliorate injury-induced cognitive impairment. Proceedings of the National Academy of Sciences of the United States of America 107(1):366–371.

Dietrich, W. D., and H. M. Bramlett. 2010. The evidence for hypothermia as a neuroprotectant in traumatic brain injury. Neurotherapeutics 7(1):43–50.

Doré, S. 2010. Mechanisms of Nutritional Neuroprotection: Neuroprotective action of the flavanol (–)-epicatechin. Presented at the IOM Nutrition and Neuroprotection in Military Personnel Workshop, Washington, DC.

Dubreuil, C. I., N. Marklund, K. Deschamps, T. K. McIntosh, and L. McKerracher. 2006. Activation of Rho after traumatic brain injury and seizure in rats. Experimental Neurology 198(2):361–369.

Faden, A. I. 2002. Neuroprotection and traumatic brain injury: Theoretical option or realistic proposition. Current Opinion in Neurology 15(6):707–712.

Ghanim, H., C. L. Sia, S. Abuaysheh, K. Korzeniewski, P. Patnaik, A. Marumganti, A. Chaudhuri, and P. Dandona. 2010. An antiinflammatory and reactive oxygen species suppressive effects of an extract of polygonum cuspidatum containing resveratrol. The Journal of Clinical Endocrinology and Metabolism 95(9):E1–E8.

Graham, D. I., T. K. McIntosh, W. L. Maxwell, and J. A. Nicoll. 2000. Recent advances in neurotrauma. Journal of Neuropathology and Experimental Neurology 59(8):641–651.

Jain, K. K. 2008. Neuroprotection in traumatic brain injury. Drug Discovery Today 13(23–24):1082–1089.

Kidd, P. M. 2007. Omega-3 DHA and EPA for cognition, behavior, and mood: Clinical findings and structural-functional synergies with cell membrane phospholipids. Alternative Medicine Review 12(3):207–227.

Kidd, P. M. 2009. Integrated brain restoration after ischemic stroke—medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity. Alternative Medicine Review 14(1):14–35.

Kokiko, O. N., and R. J. Hamm. 2007. A review of pharmacological treatments used in experimental models of traumatic brain injury. Brain Injury 21(3):259–274.

Kondo, K., S. Obitsu, S. Ohta, K. Matsunami, H. Otsuka, and R. Teshima. 2010. Poly(ADP-ribose) polymerase (PARP)-1-independent apoptosis-inducing factor (AIF) release and cell death are induced by eleostearic acid and blocked by alpha-tocopherol and MEK inhibition. Journal of Biological Chemistry 285(17):13079–13091.

Laird, M. D., S. Sukumari-Ramesh, A. E. Swift, S. E. Meiler, J. R. Vender, and K. M. Dhandapani. 2010. Curcumin attenuates cerebral edema following traumatic brain injury in mice: A possible role for aquaporin-4? Journal of Neurochemistry 113(3):637–648.

Longhi, L., K. E. Saatman, R. Raghupathi, H. L. Laurer, P. M. Lenzlinger, P. Riess, E. Neugebauer, J. Q. Trojanowski, V. M. Y. Lee, M. S. Grady, D. I. Graham, and T. K. McIntosh. 2001. A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism 21(11):1241–1258.

Love, S. 1999. Oxidative stress in brain ischemia. Brain Pathology 9(1):119–131.

Maas, A. I. R., B. Roozenbeek, and G. T. Manley. 2010. Clinical trials in traumatic brain injury: Past experience and current developments. Neurotherapeutics 7(1):115–126.

Mammis, A., T. K. McLntosh, and A. H. Maniker. 2009. Erythropoietin as a neuroprotective agent in traumatic brain injury review. Surgical Neurology 71(5):527–531.

Margulies, S., R. Hicks, and B. Combination Therapies Traumatic. 2009. Combination therapies for traumatic brain injury: Prospective considerations. Journal of Neurotrauma 26(6):925–939.

Marklund, N., A. Bakshi, D. J. Castelbuono, V. Conte, and T. K. McIntosh. 2006. Evaluation of pharmacological treatment strategies in traumatic brain injury. Current Pharmaceutical Design 12(13):1645–1680.

Marklund, N., K. Salci, A. Lewen, and L. Hillered. 1997. Glycerol as a marker for post-traumatic membrane phospholipid degradation in rat brain. Neuroreport 8(6):1457–1461.

Mattson, M. P., and S. L. Chan. 2003. Calcium orchestrates apoptosis. Nature Cell Biology 5(12):1041–1043.

Mattson, M. P., W. Z. Duan, S. L. Chan, A. W. Cheng, N. Haughey, D. S. Gary, Z. H. Guo, J. W. Lee, and K. Furukawa. 2002. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: Modification by genes, diet and behavior. Neurobiology of Aging 23(5):695–705.

Moppett, I. K. 2007. Traumatic brain injury: Assessment, resuscitation and early management. British Journal of Anaesthesia 99(1):18–31.

Morales, D. M., N. Marklund, D. Lebold, H. J. Thompson, A. Pitkanen, W. L. Maxwell, L. Longhi, H. Laurer, M. Maegele, E. Neugebauer, D. I. Graham, N. Stocchetti, and T. K. McIntosh. 2005. Experimental models of traumatic brain injury: Do we really need to build a better mousetrap? Neuroscience 136(4):971–989.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement